With sodium humate and water retaining agent in different proportions, the application effect of lettuce was studied. The test results showed that compared with the control, the simultaneous application of sodium humate and water retention agent showed a positive effect on the growth of lettuce, and the plant height of the three experimental groups increased by 20.63%, 46.87%, 58.75%, and the yield increased by 38.4%. ~61.3%, reaching a significant level; in terms of quality, the Vc content of lettuce in the three experimental groups increased by 17.25%, 28.6%, and 46.54% compared with the control, and the crude protein content increased by 16.25%, 48.01%, and 34.46%, respectively. Nitrate content decreased by 19.68%, 28.37%, and 33.62%, respectively. The application of 7:3 sodium humate and water retention agent was the best under the condition of equal nitrogen, phosphorus and potassium nutrients.
GMP in China's veterinary drug industry began to be implemented in the late 1980s. In 1989, the Ministry of agriculture of the people's Republic of China issued the code for quality management of veterinary drug production (for Trial Implementation), and in 1994, the detailed rules for the implementation of the code for quality management of veterinary drug production (for Trial Implementation). From October 1, 1995, all qualified drug manufacturers (workshops) and drug varieties can apply for GMP certification according to the requirements. The administrative department of health shall give priority to the enterprises (workshops) that have obtained the GMP certification certificate when applying for the production of new drugs. As of June 30, 1998, for enterprises (workshops) that have not obtained GMP certification, the administrative department of health will no longer accept applications for new drug production.
On March 19, 2002, the Ministry of agriculture revised and issued the new veterinary drug production quality management specification (hereinafter referred to as veterinary drug GMP specification). Announcement No. 202 was issued on June 14 of the same year, stipulating that the transition period from June 19, 2002 to December 31, 2005 is the implementation of GMP for veterinary drugs, which shall be enforced from January 1, 2006. Since then, China has poured out a large number of GMP veterinary drug enterprises
The oral liquid veterinary drugs of our factory include multi vitamins, vitamin B, enrofloxacin, ciprofloxacin, totrozuli, diclazuli, albendazole, levamisole, temicaocin, etc.
Veterinary drugs refer to substances (including drug feed additives) used to prevent, treat and diagnose animal diseases or purposefully regulate animal physiological functions.
Veterinary drugs mainly include: serum products, vaccines, diagnostic products, micro ecological products, traditional Chinese medicine, Chinese patent medicine, chemicals, antibiotics, biochemical drugs, radioactive drugs, topical pesticides, disinfectants, etc.GMP in China's veterinary drug industry began to be implemented in the late 1980s. In 1989, the Ministry of agriculture of the people's Republic of China issued the code for quality management of veterinary drug production (for Trial Implementation), and in 1994, the detailed rules for the implementation of the code for quality management of veterinary drug production (for Trial Implementation). From October 1, 1995, all qualified drug manufacturers (workshops) and drug varieties can apply for GMP certification according to the requirements. The administrative department of health shall give priority to the enterprises (workshops) that have obtained the GMP certification certificate when applying for the production of new drugs. As of June 30, 1998, for enterprises (workshops) that have not obtained GMP certification, the administrative department of health will no longer accept applications for new drug production.
On March 19, 2002, the Ministry of agriculture revised and issued the new veterinary drug production quality management specification (hereinafter referred to as veterinary drug GMP specification). Announcement No. 202 was issued on June 14 of the same year, stipulating that the transition period from June 19, 2002 to December 31, 2005 is the implementation of GMP for veterinary drugs, which shall be enforced from January 1, 2006. Since then, China has poured out a large number of GMP veterinary drug enterprises
Veterinary Oral Solution OEM&ODM,Enrofloxacin Oral Solution,Veterinary Oral Solution,Vitamin B Oral Solution Factory,Ciprofloxacin Oral Solution OEM,Veterinary Oral Solution ODM
Shandong Unovet Pharmaceutical Co.,Ltd. , https://www.unovetcn.com